Kazi Mahmood

Kazi Mahmood

Journalist since the 1980's, worked for the BBC Radio in Africa and now owns two news portals. WF is my passion too and it is about humanity and why we should stop wars.
Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron
Amubarvimab

Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron

DURHAM, N.C. and BEIJING, Dec. 12, 2021 /PRNewswire/ — Brii Biosciences Limited (stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced new in vitro pseudoviris neutralization data demonstrating that its amubarvimab/romlusevimab combination therapy (previously
4 min read